Drug Shortage Report for AURO-VALSARTAN HCT

Last updated on 2025-05-12 History
Report ID 235918
Drug Identification Number 02408120
Brand name AURO-VALSARTAN HCT
Common or Proper name AURO-VALSARTAN HCT
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 160MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100's
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-12-05
Estimated end date 2025-05-30
Actual end date
Shortage status Actual shortage
Updated date 2025-05-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2025-05-12 French Compare
v22 2025-05-12 English Compare
v21 2025-04-23 French Compare
v20 2025-04-23 English Compare
v19 2025-04-02 French Compare
v18 2025-04-02 English Compare
v17 2025-01-30 French Compare
v16 2025-01-30 English Compare
v15 2024-12-17 French Compare
v14 2024-12-17 English Compare
v13 2024-12-06 English Compare
v12 2024-12-05 French Compare
v11 2024-12-05 English Compare
v10 2024-12-04 English Compare
v9 2024-12-03 French Compare
v8 2024-12-03 English Compare
v7 2024-12-03 French Compare
v6 2024-12-03 English Compare
v5 2024-12-03 French Compare
v4 2024-12-03 English Compare

Showing 1 to 20 of 23